Compass Therapeutics Inc (NASDAQ: CMPX) is 94.48% higher on its value in year-to-date trading and has touched a low of $0.76 and a high of $3.13 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CMPX stock was last observed hovering at around $2.65 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $2.82, the stock is 38.27% and 62.63% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.59 million and changing 6.42% at the moment leaves the stock 87.61% off its SMA200. CMPX registered 103.61% gain for a year compared to 6-month gain of 168.57%. The firm has a 50-day simple moving average (SMA 50) of $1.7156 and a 200-day simple moving average (SMA200) of $1.49739.
The stock witnessed a 86.75% loss in the last 1 month and extending the period to 3 months gives it a 57.54%, and is 8.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.73% over the week and 15.16% over the month.
Compass Therapeutics Inc (CMPX) has around 32 employees, a market worth around $388.00M and $0.85M in sales. Profit margin for the company is -5618.71%. Distance from 52-week low is 268.63% and -9.87% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.00%).
The EPS is expected to shrink by -6.06% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Compass Therapeutics Inc (CMPX) Top Institutional Holders
112.0 institutions hold shares in Compass Therapeutics Inc (CMPX), with institutional investors hold 84.06% of the company’s shares. The shares outstanding are 137.59M, and float is at 83.22M with Short Float at 2.66%. Institutions hold 73.55% of the Float.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 22.36 million shares valued at $22.36 million. The investor’s holdings represent 16.3701% of the CMPX Shares outstanding. As of 2024-06-30, the second largest holder is ADAGE CAPITAL PARTNERS GP, L.L.C. with 11.13 million shares valued at $11.13 million to account for 8.1474 of the shares outstanding. The other top investors are BLACKSTONE INC. which holds 7.69 million shares representing 5.6304% and valued at over $7.69 million, while BLACKROCK INC. holds 4.8413 of the shares totaling 6.61 million with a market value of $6.61 million.
Compass Therapeutics Inc (CMPX) Insider Activity
#####
